Author:
Ardhanareeswaran Karthikeyan
Publisher
Springer International Publishing
Reference5 articles.
1. Chez, M. G., Buchanan, T. M., Becker, M., Kessler, J., Aimonovitch, M. C., & Mrazek, S. R. (2003). Donepezil hydrochloride: A double-blind study in autistic children. Journal of Pediatric Neurology, 1(2), 83–88.
2. Doyle, R. L., Frazier, J., Spencer, T. J., Geller, D., Biederman, J., & Wilens, T. (2006). Donepezil in the treatment of ADHD-Like symptoms in youths with pervasive developmental disorder a case series. Journal of Attention Disorders, 9(3), 543–549.
3. Handen, B. L., Johnson, C. R., McAuliffe-Bellin, S., Murray, P. J., & Hardan, A. Y. (2011). Safety and efficacy of donepezil in children and adolescents with autism: Neuropsychological measures. Journal of Child and Adolescent Psychopharmacology, 21(1), 43–50.
4. Hardan, A. Y., & Handen, B. L. (2002). A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder. Journal of Child and Adolescent Psychopharmacology, 12(3), 237–241.
5. Yoo, J. H., Valdovinos, M. G., & Williams, D. C. (2007). Relevance of donepezil in enhancing learning and memory in special populations: A review of the literature. Journal of Autism and Developmental Disorders, 37(10), 1883–1901.